Feedback / Questions
23ME-01473 - 23andMe
https://www.globenewswire.com/news-release/2024/03/20/2849267/0/en/23andMe-Initiates-Phase-1-Clinical-Trial-for-its-Dual-Mechanism-Antibody-23ME-01473-Targeting-ULBP6.html
Mar 20, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next